AS Kevelt-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:AS Kevelt - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011846
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:エストニア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AS Kevelt (Kevelt), a subsidiary of Pharmsynthez is a healthcare company that develops, manufactures and markets drug products. The company offers products which include concentrate solutions for infusion, endocervical gel, eye drops and other solutions. It also offers sub-contracting and distribution services. Kevelt provides pharma-co-vigilance facilities for maintenance of safety of pharmaceuticals administered to patients. The company’s sub-contracting services comprise sub-contract production, quality control, re-packaging and re-labeling and import services. Its products are used in treatment of obstetrics, peripheral vascular diseases and Glaucoma, elevated intraocular pressure. Kevelt is headquartered in Tallinn, Estonia.

AS Kevelt – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AS Kevelt, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AS Kevelt, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AS Kevelt, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AS Kevelt, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
AS Kevelt, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
AS Kevelt, Pharmaceuticals & Healthcare, Deal Details 10
Asset Transactions 10
Xenetic Biosciences Acquires Rights to Virexxa from Kevelt 10
Acquisition 11
Farmsintez to Acquire Stake in Kevelt for USD2.4 Million 11
Pharmsynthez Completes Acquisition Of Kevelt, Outsourced Manufacturer 12
AS Kevelt – Key Competitors 13
AS Kevelt – Key Employees 14
AS Kevelt – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
AS Kevelt, Pharmaceuticals & Healthcare, Key Facts 2
AS Kevelt, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AS Kevelt, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AS Kevelt, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AS Kevelt, Deals By Therapy Area, 2011 to YTD 2017 8
AS Kevelt, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Xenetic Biosciences Acquires Rights to Virexxa from Kevelt 10
Farmsintez to Acquire Stake in Kevelt for USD2.4 Million 11
Pharmsynthez Completes Acquisition Of Kevelt, Outsourced Manufacturer 12
AS Kevelt, Key Competitors 13
AS Kevelt, Key Employees 14

★海外企業調査レポート[AS Kevelt-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Heat Biologics Inc (HTBX)-製薬・医療分野:企業M&A・提携分析
    Summary Heat Biologics Inc (Heat Biologics) is an immuno-oncology company that develops novel therapies to activate patient’s immune system against cancer. The company develops immune pan-antigen cytotoxic therapy, which is a therapeutic vaccine used in the treatment of cancer and infectious disease …
  • Pearson plc (PSON):企業の財務・戦略的SWOT分析
    Pearson plc (PSON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Cascadian Therapeutics Inc (CASC):企業財務及び戦略的SWOT分析
    Summary Cascadian Therapeutics Inc (Cascadian) formerly Oncothyreon Inc. is a clinical-stage biotechnology company that develops therapeutic products for the treatment of cancer. The company’s lead clinical-stage product candidate includes ONT-380, an orally active and selective small-molecule HER2 …
  • EpiZyme, Inc. (EPZM)(製薬・医療分野):企業M&A動向
    Summary EpiZyme, Inc. (Epizyme) is a biopharmaceutical company. The company discovers and develops molecular targeted drugs for the treatment of oncology and metabolic diseases. Epizyme’s products include DOT1L and EZH2. The company’s product, DOT1L is used in the treatment of leukemia and EZH2 is u …
  • Unilever Pakistan Limited:企業の戦略・SWOT・財務分析
    SummaryUnilever Pakistan Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • Shaw Communications, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Shaw Communications, Inc. Merge …
  • Crisil Ltd (CRISIL):企業財務及び戦略的SWOT分析
    Summary Crisil Ltd (Crisil), a subsidiary of S&P Global Inc. is a financial services company that offers risk management services. The company provides ratings, research and risk and policy advisory services. It offers services such as credit ratings, business school gradings, real estate star ratin …
  • Hong Kong Aircraft Engineering Company Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Hong Kong Aircraft Engineering …
  • Nichols plc:企業の戦略・SWOT・財務分析
    SummaryNichols plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Hibu Group Limited:戦略・SWOT・企業財務分析
    Hibu Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hibu Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Arbor Pharmaceuticals, LLC.(製薬・医療分野):企業M&A動向
    Summary Arbor Pharmaceuticals, LLC. (Arbor) is a specialty pharmaceutical company that offers prescription products for the hospital, cardiovascular and pediatric markets. The company undertakes licensing, development and commercialization of late-stage products. Arbor’s products cover a range of th …
  • BioLight Israeli Life Sciences Ltd (BOLT):企業のM&A・提携動向(医療機器分野)
    Summary BioLight Israeli Life Sciences Ltd (Bio-Light) is an ophthalmic company that concentrates on the discovery, development and commercialization of products and product candidates that address ophthalmic conditions; including glaucoma, dry eye syndrome, or DES, and age-related macular degenerat …
  • Orion Bank:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Orion Bank Mergers and Acquisit …
  • Thai President Foods Plc (TF):企業概要、財務及び戦略的SWOT分析
    Summary Thai President Foods Plc (TF) is a food manufacturing company. The company manufactures and distributes instant noodles and biscuit products. Its products include crackers, wafers, cookies, and fruit juices. TF offers its products in different flavours such as butter coconut, butter coconut …
  • North China Pharmaceutical Co., Ltd. (600812):企業の財務及び戦略的SWOT分析
    Summary North China Pharmaceutical Co., Ltd. (NCPC), a subsidiary of China Pharmaceutical Group is a pharmaceutical company that develops, produces and sells novel drugs and pharmaceutical related products. The company’s products include benproperine phosphate, vitamin EC particles, bismuth potassiu …
  • Nufarm Limited:企業の戦略・SWOT・財務分析
    SummaryNufarm Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • John Menzies plc:戦略・SWOT・企業財務分析
    John Menzies plc - Strategy, SWOT and Corporate Finance Report Summary John Menzies plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Maersk Olie og Gas AS:企業のM&A・提携動向(石油・ガス分野)
    Summary Maersk Olie og Gas AS (Maersk Oil), a subsidiary of A.P. Moller – Maersk AS, is an oil and gas exploration and production company. The company undertakes exploration and development activities for natural gas and crude oil in Angola, Greenland, Norway, the US Gulf of Mexico and other produci …
  • Providence Health and Services:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Providence Health and Services …
  • “KOKS” Open Joint-Stock Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' "KOKS" Open Joint-Stock Company …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆